Status:
WITHDRAWN
Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite
Lead Sponsor:
Research Center Borstel
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to examine wether the combination of Ramatroban/Montelukast is as effective as Montelukast alone in patients with mild to moderate atopic asthma (GINA I and II) sensitive ...
Detailed Description
In the early allergic response in asthma, allergens connect to IgE on mast cells and basophile granulocytes. For that there are 3 main pathways in activation: Besides quick liberation of Histamine an...
Eligibility Criteria
Inclusion
- Atopic (house dust mite) asthma
- Severity GINA one and two
Exclusion
- No reaction in specific bronchial provocation test
- Other kind of clinical relevant atopic reaction
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00311051
Start Date
April 1 2005
End Date
April 1 2007
Last Update
April 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Center Borstel
Borstel, Germany, 23845